At lest 43 patients administered intravitreal (eye) injections of a drug containing the steroid triamcinolone and the anti-infective moxifloxacin compounded by Guardian Pharmacy Services in Dallas, Texas, suffered adverse events following cataract surgery. The Food and Drug Administration (FDA) alerted ophthalmologists, pharmacists and patients in a Safety Communication. The patients were administered Guardian’s product at the end of a cataract surgery procedure at PRG Dallas Ambulatory Surgery Center in Dallas by physicians affiliated with the Key Whitman Eye Center, and at the Park Central Surgical Center in Dallas by physicians with Tylock-George Eye Care. According to the FDA’s reports, the ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.